Frank Kullmann

发表

Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial

W. Scheithauer, P. Wirapati, V. Heinemann, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial.

W. Scheithauer, P. Wirapati, H. Lenz, 2017 .

Characterization of bile salt-induced apoptosis in colon cancer cell lines.

G. Rogler, J. Schölmerich, R. Krieg, 2000, Cancer research.

Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study

A. Hinke, J. Trojan, S. Hollerbach, 2009, British Journal of Cancer.

Transcatheter arterial embolisation in upper gastrointestinal bleeding in a sample of 29 patients in a gastrointestinal referral center in Germany

A. Schreyer, T. Finkenzeller, C. Paetzel, 2015, Zeitschrift für Gastroenterologie.

Gene expression pattern of laser microdissected colonic crypts of adenomas with low grade dysplasia

U. Müller-Ladner, J. Schölmerich, J. Rüschoff, 2003, Gut.

A randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer

K. Caca, S. Al-Batran, E. Jäger, 2013, British Journal of Cancer.

Impact of BRAF and RAS mutations on first-line efficacy of FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab: analysis of the FIRE-3 (AIO KRK-0306) study.

A. Kiani, S. Al-Batran, T. Kirchner, 2017, European journal of cancer.

Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer

F. Lordick, C. Peschel, J. Duyster, 2005, British Journal of Cancer.

Glutamine attenuates leukocyte-endothelial cell adhesion in indomethacin-induced intestinal inflammation in the rat.

J. Schölmerich, F. Kullmann, K. Palitzsch, 1999, JPEN. Journal of parenteral and enteral nutrition.

Beneficial effect of ursodeoxycholic acid on mucosal damage in trinitrobenzene sulphonic acid-induced colitis.

J. Schölmerich, J. Rüschoff, V. Gross, 1997, European journal of gastroenterology & hepatology.

Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial

P. Schőffski, G. Folprecht, S. Al-Batran, 2008, British Journal of Cancer.

Subclinical hepatic encephalopathy: the diagnostic value of evoked potentials.

J. Schölmerich, S. Hollerbach, A. Holstege, 1995, Journal of hepatology.